// API callback
Tabletop.singleton.loadSheet({"version":"1.0","encoding":"UTF-8","feed":{"xmlns":"https://www.w3.org/2005/Atom","xmlns$openSearch":"https://a9.com/-/spec/opensearchrss/1.0/","xmlns$gsx":"https://schemas.google.com/spreadsheets/2006/extended","id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"Sheet1"},"link":[{"rel":"alternate","type":"application/atom+xml","href":"https://docs.google.com/spreadsheets/d/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/pubhtml"},{"rel":"https://schemas.google.com/g/2005#feed","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values"},{"rel":"https://schemas.google.com/g/2005#post","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values"},{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values?alt\u003djson-in-script"}],"author":[{"name":{"$t":"henry.m.drysdale"},"email":{"$t":"henry.m.drysdale@gmail.com"}}],"openSearch$totalResults":{"$t":"67"},"openSearch$startIndex":{"$t":"1"},"entry":[{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cokwr"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"1"},"content":{"type":"text","$t":"weekbeginning: 19/10/2015, journalname: NEJM, trialtitle: A Randomized, Controlled Trial of Total Knee Replacement, publicationdate: 22/10/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1505467, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01410409, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 25/10/2015, completiondate: 28/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1BISudLrrwteQ47v9ELbRPZ0dq7wwlPn1WNwVrW_FBFU/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 29/10/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/11hRbRe2kcGu4Aago0qYzP6lbaESJrJ0K3JR2l3DBKWU/edit, lettercheckedbybgorch-initialanddate: BG 4th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 04/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cokwr"}],"gsx$studyid":{"$t":"1"},"gsx$weekbeginning":{"$t":"19/10/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"A Randomized, Controlled Trial of Total Knee Replacement"},"gsx$publicationdate":{"$t":"22/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1505467"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01410409"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"28/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1BISudLrrwteQ47v9ELbRPZ0dq7wwlPn1WNwVrW_FBFU/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"29/10/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":""},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/11hRbRe2kcGu4Aago0qYzP6lbaESJrJ0K3JR2l3DBKWU/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"04/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cpzh4"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"2"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention, publicationdate: 22/10/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1506197, linktoonlinereistryentryfortrial: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN\u003d12612000625875, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1506197/suppl_file/nejmoa1506197_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Henry Drysdale, assigneddate: 25/10/2015, completiondate: 28/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1EhiJbn-WBdiFiLckQQrEG0IpCERgr4E4bEEIdPGixuE/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 30/10/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 10, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1vx_Cb0f1EeiQLoMPieUQZ2ZXFnNneGMKmWycUrY2sZ0/edit, lettercheckedbybgorch-initialanddate: BG 4th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 05/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cpzh4"}],"gsx$studyid":{"$t":"2"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention"},"gsx$publicationdate":{"$t":"22/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1506197"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN\u003d12612000625875"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1506197/suppl_file/nejmoa1506197_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"28/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1EhiJbn-WBdiFiLckQQrEG0IpCERgr4E4bEEIdPGixuE/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"30/10/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"10"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":""},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1vx_Cb0f1EeiQLoMPieUQZ2ZXFnNneGMKmWycUrY2sZ0/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"05/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cre1l"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"3"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer, publicationdate: 22/10/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1507643, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT01673867/2012_10_24, linktopre-trialprotocolifavailable: https://drive.google.com/open?id\u003d0B2r5CjEdwpx_MWVGSV8tQ2VlX3c, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 25/10/2015, completiondate: 28/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/148aDkt-JstDnGBhqNdTZp8fPWCkRbLRsi4BRqlbu76g/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 29/10/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, secondassessordiscrepanciesfreetext: Query regarding non-prespecified outcomes and table: Table 2 doesn't seem to refer at all to primary or secondary outcomes. Figure 2, on the other hand, is where the data is, amongst other data., totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Not sure, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1zE1wPf-FBonKr6fzWXWnpDIYeWN3qdGe5_4qEH71pN4/edit, lettercheckedbybgorch-initialanddate: BG 4th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 05/11/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12, complicationsandmattersarisinginfreetext: The primary outcome is marked as unreported for this trial as the authors report mortality according to a March 2015 datalock and not 24 months as stated in the trial protocol. It can, however be inferred from figure 2. The letter for this article is currently unfinished."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cre1l"}],"gsx$studyid":{"$t":"3"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer"},"gsx$publicationdate":{"$t":"22/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1507643"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT01673867/2012_10_24"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://drive.google.com/open?id\u003d0B2r5CjEdwpx_MWVGSV8tQ2VlX3c"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"28/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/148aDkt-JstDnGBhqNdTZp8fPWCkRbLRsi4BRqlbu76g/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"29/10/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Query regarding non-prespecified outcomes and table: Table 2 doesn't seem to refer at all to primary or secondary outcomes. Figure 2, on the other hand, is where the data is, amongst other data."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Not sure"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1zE1wPf-FBonKr6fzWXWnpDIYeWN3qdGe5_4qEH71pN4/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"05/11/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"The primary outcome is marked as unreported for this trial as the authors report mortality according to a March 2015 datalock and not 24 months as stated in the trial protocol. It can, however be inferred from figure 2. The letter for this article is currently unfinished."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/chk2m"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"4"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain, publicationdate: 20/10/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2463257, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01587274, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 25/10/2015, completiondate: 27/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1SGn7DA_4c4roEBfIGywmTx1V4FGfzpC0D5CdxGfNP0Q/edit#gid\u003d0, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 0, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 5, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 5, firstassessoropinion-letterrequired: No, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: Letter not required, lettersubmissiondeadline: #REF!, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 4/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/chk2m"}],"gsx$studyid":{"$t":"4"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain"},"gsx$publicationdate":{"$t":"20/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2463257"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01587274"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"27/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1SGn7DA_4c4roEBfIGywmTx1V4FGfzpC0D5CdxGfNP0Q/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"5"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"5"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":""},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"Letter not required"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":""},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 4/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ciyn3"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"5"},"content":{"type":"text","$t":"journalname: Ann Intern Med., trialtitle: Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial, publicationdate: 13/10/2015, linktoonlinetrialreport: https://annals.org/article.aspx?articleid\u003d2456121, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT00784433?term\u003dcascade+alcohol\u0026rank\u003d1, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 25/10/2015, completiondate: 27/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1qftvTP-4JrI1SxV7cu6588_kiwICY7bolwP6L4vlWWI/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 29/10/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 1, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 14, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/13rfaG2bfiOftob9XfnsT2SNycMGP1KonOqWslmfibRA/edit, lettercheckedbybgorch-initialanddate: BG 4th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 09/11/2015, letterstatus: Letter published, letterpublisheddate: 09/11/2015, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12, complicationsandmattersarisinginfreetext: Published online on 9/11/2015, will be considered for print publication 13/11/2015"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ciyn3"}],"gsx$studyid":{"$t":"5"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Ann Intern Med."},"gsx$trialtitle":{"$t":"Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial"},"gsx$publicationdate":{"$t":"13/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://annals.org/article.aspx?articleid\u003d2456121"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT00784433?term\u003dcascade+alcohol\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"27/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1qftvTP-4JrI1SxV7cu6588_kiwICY7bolwP6L4vlWWI/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"29/10/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"14"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/13rfaG2bfiOftob9XfnsT2SNycMGP1KonOqWslmfibRA/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"09/11/2015"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Published online on 9/11/2015, will be considered for print publication 13/11/2015"}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ckd7g"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"6"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial, publicationdate: 20/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00471-7/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/study/NCT00402519, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 25/10/2015, completiondate: 27/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1q8SkvpcAbwiw38vKK5mumvT2HQXdNysLHpkhDtxvu_k/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 31/10/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 3, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: Letter not required, lettersubmissiondeadline: #REF!, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 3/12, complicationsandmattersarisinginfreetext: The time points for all data was not pre-specified in the original registry entry. There has been stratification of several secondary outcomes. Two secondary outcomes were not reported with authors stating they will be published elsewhere. One secondary outcome is not mentionned. A detailed freetext summary of the analysis is in the folder for trial 6."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ckd7g"}],"gsx$studyid":{"$t":"6"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial"},"gsx$publicationdate":{"$t":"20/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00471-7/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/study/NCT00402519"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"27/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1q8SkvpcAbwiw38vKK5mumvT2HQXdNysLHpkhDtxvu_k/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"31/10/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"Letter not required"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":""},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"The time points for all data was not pre-specified in the original registry entry. There has been stratification of several secondary outcomes. Two secondary outcomes were not reported with authors stating they will be published elsewhere. One secondary outcome is not mentionned. A detailed freetext summary of the analysis is in the folder for trial 6."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/clrrx"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"7"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial, publicationdate: 24/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60127-1/abstract, linktoonlinereistryentryfortrial: https://www.controlled-trials.com/ISRCTN75058295, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 25/10/2015, completiondate: 28/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1cQ0Rd8vtTxtxcp5dFHp1j67vW6XErsPG9H2hCBFwiJE/edit#gid\u003d0, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 6, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 17, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/174C54WJSnLzmEpQ_Eg8x0FpIm6VtanfhiGk_cxap2Vc/edit, lettercheckedbybgorch-initialanddate: BG CH 6th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 06/11/2015, letterstatus: Letter published"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/clrrx"}],"gsx$studyid":{"$t":"7"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): a primary care randomised trial"},"gsx$publicationdate":{"$t":"24/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60127-1/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.controlled-trials.com/ISRCTN75058295"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"28/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1cQ0Rd8vtTxtxcp5dFHp1j67vW6XErsPG9H2hCBFwiJE/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"17"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/174C54WJSnLzmEpQ_Eg8x0FpIm6VtanfhiGk_cxap2Vc/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG CH 6th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"06/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":""},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cyevm"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"8"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial, publicationdate: 24/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60314-2/abstract, linktoonlinereistryentryfortrial: https://www.isrctn.com/ISRCTN88559475, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Philip Hartley, assigneddate: 25/10/2015, completiondate: 29/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1AOSJC94p4UorJKWSg_pzumr8l7DVqyAMaGBfHXhNXx0/edit, assessmentcheckedbysecondassessor-date: 29/10/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, secondassessordiscrepanciesfreetext: Query on secondary outcome measure 3: different Fecal Incontinence scale used, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 10, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 8, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1P3Q9kx8WEROvsd01jQMELm_4ik6N_WAQBCp8O46We0E/edit, lettercheckedbybgorch-initialanddate: BG 6th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 06/11/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 5/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cyevm"}],"gsx$studyid":{"$t":"8"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial"},"gsx$publicationdate":{"$t":"24/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60314-2/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.isrctn.com/ISRCTN88559475"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"29/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1AOSJC94p4UorJKWSg_pzumr8l7DVqyAMaGBfHXhNXx0/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"29/10/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Query on secondary outcome measure 3: different Fecal Incontinence scale used"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"10"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"8"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1P3Q9kx8WEROvsd01jQMELm_4ik6N_WAQBCp8O46We0E/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 6th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"06/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cztg3"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"9"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial, publicationdate: 24/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61107-2/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT01520909/2012_03_09, linktopre-trialprotocolifavailable: Protocol published after start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 25/10/2015, completiondate: 29/10/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1KNGgHyhtpJxTfDhbIheP8r4k_arybAJLwJmshrthd8M/edit#gid\u003d0, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 22, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 4, numberofprespecifiedsecondaryoutcomescorrectlyreported: 10, totalnumberofnon-prespecifiedoutcomesreported: 1, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1ZUz5k8o1zA1t_knue73X7UB6XqPRKGzbPZfLCt9DZ14/edit, lettercheckedbybgorch-initialanddate: BG reviewed salient points not checked every item 6th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 06/11/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 5/12, complicationsandmattersarisinginfreetext: 10 end-points added to protocol and registry entry post trial completion date. Outcome measures spread out over multiple tables. As there is no indication as to whether their contents are outcome measures, I have taken all tables 2-7 to be reporting outcomes."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cztg3"}],"gsx$studyid":{"$t":"9"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial"},"gsx$publicationdate":{"$t":"24/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61107-2/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT01520909/2012_03_09"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"29/10/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1KNGgHyhtpJxTfDhbIheP8r4k_arybAJLwJmshrthd8M/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"22"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"10"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"1"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1ZUz5k8o1zA1t_knue73X7UB6XqPRKGzbPZfLCt9DZ14/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG reviewed salient points not checked every item 6th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"06/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"10 end-points added to protocol and registry entry post trial completion date. Outcome measures spread out over multiple tables. As there is no indication as to whether their contents are outcome measures, I have taken all tables 2-7 to be reporting outcomes."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d180g"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"10"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Neurodevelopmental outcome at 2 years of age after GA or awake-regional anaesthesia in infancy, publicationdate: 04/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00608-X/fulltext, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT00756600?term\u003dNCT00756600.\u0026rank\u003d1, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 25/10/2015, completiondate: 14/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1Dbt4whQhiBNHQx4s1CWhBCS3_Jlp1t1yXJJBDXxbf78/edit, assessmentcheckedbysecondassessor-date: 15/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: 1. Query coding of how main secondary outcome is reported. 2. It is possible that most of Table 3 and all of Table 5 should be considered non-prespecified., totalnumberofprespecifiedprimaryoutcomes: 0, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 3, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 26, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1aqNB7r8AzMGHPKdKWUu2Jox39yVn2AH4eAvDqu80fFY/edit, lettercheckedbybgorch-initialanddate: CH 17/11, lettersubmissiondeadline: #REF!, lettersentdate: 17/11/2015, letterstatus: Letter published, complicationsandmattersarisinginfreetext: Trial was registered after the trial start date"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d180g"}],"gsx$studyid":{"$t":"10"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Neurodevelopmental outcome at 2 years of age after GA or awake-regional anaesthesia in infancy"},"gsx$publicationdate":{"$t":"04/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00608-X/fulltext"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT00756600?term\u003dNCT00756600.\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"25/10/2015"},"gsx$completiondate":{"$t":"14/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1Dbt4whQhiBNHQx4s1CWhBCS3_Jlp1t1yXJJBDXxbf78/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"15/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"1. Query coding of how main secondary outcome is reported. 2. It is possible that most of Table 3 and all of Table 5 should be considered non-prespecified."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"26"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1aqNB7r8AzMGHPKdKWUu2Jox39yVn2AH4eAvDqu80fFY/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 17/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":""},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Trial was registered after the trial start date"}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d2mkx"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"13"},"content":{"type":"text","$t":"weekbeginning: 26/10/2015, journalname: NEJM, trialtitle: Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes, publicationdate: 29/10/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1510188, linktoonlinereistryentryfortrial: https://ctri.nic.in/Clinicaltrials/advsearch.php, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510188/suppl_file/nejmoa1510188_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 30/10/2015, completiondate: 01/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1jY791XpQqpvt-zxyPfHsJGISJD9syz6zQXP8sJGriTg/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 05/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Primary endpoint is a composite, reported in table. Secondary endpoints are prespecified at multiple time points but only reported at 12 months., totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 15, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 14, totalnumberofnon-prespecifiedoutcomesreported: 4, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1tAxiXWFHE8_BoqAzizkPAZg3Jb8XC6kAPHyZNiEbnv4/edit, lettercheckedbybgorch-initialanddate: BG 12th nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 07/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 5/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d2mkx"}],"gsx$studyid":{"$t":"13"},"gsx$weekbeginning":{"$t":"26/10/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes"},"gsx$publicationdate":{"$t":"29/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1510188"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://ctri.nic.in/Clinicaltrials/advsearch.php"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510188/suppl_file/nejmoa1510188_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"01/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1jY791XpQqpvt-zxyPfHsJGISJD9syz6zQXP8sJGriTg/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"05/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Primary endpoint is a composite, reported in table. Secondary endpoints are prespecified at multiple time points but only reported at 12 months."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"15"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"14"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"4"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1tAxiXWFHE8_BoqAzizkPAZg3Jb8XC6kAPHyZNiEbnv4/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 12th nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"07/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cssly"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"14"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care UnitThe SPLIT Randomized Clinical Trial, publicationdate: 27/10/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2454911, linktoonlinereistryentryfortrial: https://www.anzctr.org.au/trial_view.aspx?ACTRN\u003dACTRN12613001370796, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/data/Journals/JAMA/934616/JOI150118supp1_prod.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 30/10/2015, completiondate: 02/11/2015, linktoassessment: https://drive.google.com/open?id\u003d13tGwajYMRg0cxCZvHnMfsWT4HTvo1fNzvFOgp5fQhpI, assessmentcheckedbysecondassessor-date: 06/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 12, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 12, totalnumberofnon-prespecifiedoutcomesreported: 1, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: No, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: Letter not required, lettersubmissiondeadline: #REF!, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 5/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cssly"}],"gsx$studyid":{"$t":"14"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care UnitThe SPLIT Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"27/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2454911"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.anzctr.org.au/trial_view.aspx?ACTRN\u003dACTRN12613001370796"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/data/Journals/JAMA/934616/JOI150118supp1_prod.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"02/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d13tGwajYMRg0cxCZvHnMfsWT4HTvo1fNzvFOgp5fQhpI"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"06/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"12"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"12"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"1"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"No"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"Letter not required"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":""},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cu76f"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"15"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory FailureA Randomized Clinical Trial, publicationdate: 27/10/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2454912, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01915719, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/data/Journals/JAMA/934616/JOI150119supp1_prod.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 30/10/2015, completiondate: 02/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1M8br026UdJ4PXWbwIrbKdemngdZqMDpmEMnfWcpG3Dc, assessmentcheckedbysecondassessor-date: 06/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Query whether first secondary outcome listed in assessment sheet is actually an outcome, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 2, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 1, firstassessoropinion-letterrequired: Not sure, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1c1szuGLIo-0JcRNSyJS9zHMrgcVFdcbbYw9LZG1Na50, lettercheckedbybgorch-initialanddate: BG Nov 12 2015, lettersubmissiondeadline: #REF!, lettersentdate: 12/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 5/12, complicationsandmattersarisinginfreetext: Discrepancy between french protocol document and registry entry. Subjective statement ('good') that isn't justified or explained. Addition of 6 month mortality (many other outcomes were monitored at this point)"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cu76f"}],"gsx$studyid":{"$t":"15"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory FailureA Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"27/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2454912"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01915719"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/data/Journals/JAMA/934616/JOI150119supp1_prod.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"02/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1M8br026UdJ4PXWbwIrbKdemngdZqMDpmEMnfWcpG3Dc"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"06/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Query whether first secondary outcome listed in assessment sheet is actually an outcome"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"2"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"1"},"gsx$firstassessoropinion-letterrequired":{"$t":"Not sure"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1c1szuGLIo-0JcRNSyJS9zHMrgcVFdcbbYw9LZG1Na50"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG Nov 12 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"12/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Discrepancy between french protocol document and registry entry. Subjective statement ('good') that isn't justified or explained. Addition of 6 month mortality (many other outcomes were monitored at this point)"}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cvlqs"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"16"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma The BELT Randomized Clinical Trial, publicationdate: 27/10/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2466145, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01290874, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 30/10/2015, completiondate: 04/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1YpDi1uc8R1Y94mW1mY9J_imLFM8TPTvmuCd0yadpdTc, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1M8r84vaBDKSGFHi90tWdljZ27VvI6-0b1qwde_nAqR8, lettercheckedbybgorch-initialanddate: BG Nov 12 2015 , lettersubmissiondeadline: #REF!, lettersentdate: 12/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 5/12, complicationsandmattersarisinginfreetext: Primary outcomes changed in most recent version of protocol (no earlier versions available) but not in registry. No trial results table, but reported in figures with slight discrepancies in time points. Supplementary material also outlines tables that could be used to display comparison, but these are not in the report."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cvlqs"}],"gsx$studyid":{"$t":"16"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma The BELT Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"27/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2466145"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01290874"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"04/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1YpDi1uc8R1Y94mW1mY9J_imLFM8TPTvmuCd0yadpdTc"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1M8r84vaBDKSGFHi90tWdljZ27VvI6-0b1qwde_nAqR8"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG Nov 12 2015 "},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"12/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Primary outcomes changed in most recent version of protocol (no earlier versions available) but not in registry. No trial results table, but reported in figures with slight discrepancies in time points. Supplementary material also outlines tables that could be used to display comparison, but these are not in the report."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cx0b9"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"17"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial, publicationdate: 28/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00548-6/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT00828087, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 30/10/2015, completiondate: 03/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1lDT0Pchhcoa4U_Y5wFjdd54cv4eGuIijfYEekIsqCbY/edit#gid\u003d0, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 8, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 2, numberofprespecifiedsecondaryoutcomescorrectlyreported: 5, totalnumberofnon-prespecifiedoutcomesreported: 11, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1-CgvflgB7mhWxBdl1ze9OXxSZTZWfnhsElMMDGeH8mw/edit?usp\u003ddrive_web, lettercheckedbybgorch-initialanddate: BG 9th Nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 09/11/2015, letterstatus: Letter published, letterpublisheddate: 14/05/2016, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 10/12, complicationsandmattersarisinginfreetext: Registry entry was first received 1 month after trial start date. "},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/cx0b9"}],"gsx$studyid":{"$t":"17"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial"},"gsx$publicationdate":{"$t":"28/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00548-6/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT00828087"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"03/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1lDT0Pchhcoa4U_Y5wFjdd54cv4eGuIijfYEekIsqCbY/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"2"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"5"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"11"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1-CgvflgB7mhWxBdl1ze9OXxSZTZWfnhsElMMDGeH8mw/edit?usp\u003ddrive_web"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9th Nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"14/05/2016"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 10/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Registry entry was first received 1 month after trial start date. "}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d9ney"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"18"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial, publicationdate: 31/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61485-4/abstract, linktoonlinereistryentryfortrial: https://www.isrctn.com/ISRCTN67937027, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 30/10/2015, completiondate: 03/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1H0-ymJJEE4sCJlV1Av8VCvKmdipczLIUhcnov0urUBk/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 02/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 1, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1r1sFiPftzLei2hIDVue_rqdb_7jBN-MGZ1W7BGKWXPY/edit, lettercheckedbybgorch-initialanddate: BG 9th Nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 10/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 11/12, complicationsandmattersarisinginfreetext: This trial was well reported except for the addition of a secondary outcome that was not pre-specified. However, the trial registry was edited after the trial was reported and a record of the changes is unavailable."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d9ney"}],"gsx$studyid":{"$t":"18"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial"},"gsx$publicationdate":{"$t":"31/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)61485-4/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.isrctn.com/ISRCTN67937027"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"03/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1H0-ymJJEE4sCJlV1Av8VCvKmdipczLIUhcnov0urUBk/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"02/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"1"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1r1sFiPftzLei2hIDVue_rqdb_7jBN-MGZ1W7BGKWXPY/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9th Nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"10/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 11/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"This trial was well reported except for the addition of a secondary outcome that was not pre-specified. However, the trial registry was edited after the trial was reported and a record of the changes is unavailable."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/db1zf"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"19A"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials, publicationdate: 31/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60031-9/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01163032, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 30/10/2015, completiondate: 03/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/12fI0H7scD_YVoM-gV3p-tNbhN4vAh9sSfgmJKOV6Ykc/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 02/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 8, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 3, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1rAXp8VsSv-SRQnk7xXt6al5wf5YZmb3o5SydWXjXyCg/edit, lettercheckedbybgorch-initialanddate: BG 9th Nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 10/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 11/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/db1zf"}],"gsx$studyid":{"$t":"19A"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials"},"gsx$publicationdate":{"$t":"31/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60031-9/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01163032"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"03/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/12fI0H7scD_YVoM-gV3p-tNbhN4vAh9sSfgmJKOV6Ykc/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"02/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1rAXp8VsSv-SRQnk7xXt6al5wf5YZmb3o5SydWXjXyCg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9th Nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"10/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 11/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dcgjs"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"19B"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials, publicationdate: 31/10/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60031-9/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01430754, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 30/10/2015, completiondate: 04/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1g2HUN2Ga9SyxyX5c_B04u023u85LP6dkwuEvFAjbAvI/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 02/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 5, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1rAXp8VsSv-SRQnk7xXt6al5wf5YZmb3o5SydWXjXyCg/edit, lettercheckedbybgorch-initialanddate: BG 9th Nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 10/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 11/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dcgjs"}],"gsx$studyid":{"$t":"19B"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials"},"gsx$publicationdate":{"$t":"31/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)60031-9/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01430754"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"04/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1g2HUN2Ga9SyxyX5c_B04u023u85LP6dkwuEvFAjbAvI/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"02/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1rAXp8VsSv-SRQnk7xXt6al5wf5YZmb3o5SydWXjXyCg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9th Nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"10/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 11/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ddv49"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"20"},"content":{"type":"text","$t":"journalname: BMJ, trialtitle: Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial), publicationdate: 28/10/2015, linktoonlinetrialreport: https://www.bmj.com/content/351/bmj.h5364, linktoonlinereistryentryfortrial: https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001941-42/SE, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 30/10/2015, completiondate: 05/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1KzdSAuo2ENMQvIIeMrU8Cpe17tB1Blc7-wjMesSlkLM, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 18, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 18, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: No, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: Letter not required, lettersubmissiondeadline: BMJ, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 5/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ddv49"}],"gsx$studyid":{"$t":"20"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"BMJ"},"gsx$trialtitle":{"$t":"Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)"},"gsx$publicationdate":{"$t":"28/10/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.bmj.com/content/351/bmj.h5364"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-001941-42/SE"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"30/10/2015"},"gsx$completiondate":{"$t":"05/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1KzdSAuo2ENMQvIIeMrU8Cpe17tB1Blc7-wjMesSlkLM"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"18"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"18"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"No"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"Letter not required"},"gsx$lettersubmissiondeadline":{"$t":"BMJ"},"gsx$lettersentdate":{"$t":""},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 5/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d415a"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"22"},"content":{"type":"text","$t":"weekbeginning: 02/11/2015, journalname: NEJM, trialtitle: Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma, publicationdate: 05/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1510016, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01865747?term\u003dNCT01865747\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510016/suppl_file/nejmoa1510016_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 06/11/2015, completiondate: 15/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1TCRUUZO5jSm0IVEklPkNPjKkYkDMUtp47j7C0NUxPBE/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 15/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Query coding of primary and secondary outcomes - see comments on assessment sheet, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 15, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1lPdVjFMGhVeGVeiUbh9LOit2qXzqKVt-RuEffRSoTf4/edit, lettercheckedbybgorch-initialanddate: BG 23 nov 15 (didn't check all negatives, agree additional endpoints shld be reported), lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 10/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d415a"}],"gsx$studyid":{"$t":"22"},"gsx$weekbeginning":{"$t":"02/11/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma"},"gsx$publicationdate":{"$t":"05/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1510016"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01865747?term\u003dNCT01865747\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510016/suppl_file/nejmoa1510016_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"15/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1TCRUUZO5jSm0IVEklPkNPjKkYkDMUtp47j7C0NUxPBE/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"15/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Query coding of primary and secondary outcomes - see comments on assessment sheet"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"15"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1lPdVjFMGhVeGVeiUbh9LOit2qXzqKVt-RuEffRSoTf4/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 23 nov 15 (didn't check all negatives, agree additional endpoints shld be reported)"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 10/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d5fpr"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"23"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma, publicationdate: 05/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1510665, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01668784, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510665/suppl_file/nejmoa1510665_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Henry Drysdale, assigneddate: 06/11/2015, completiondate: 11/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1P2zM4DRXAmWl_RLJs5PpxsTe2CkWSqE1vdPPNnmEWco/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 13/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Differences between protocol and registry entry., totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 7, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 3, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 1, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1vFXq21LzlZkjL2DalVavgMjCbU_7A9VycpY0zO9vTwQ, lettercheckedbybgorch-initialanddate: KM 18/11, lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d5fpr"}],"gsx$studyid":{"$t":"23"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma"},"gsx$publicationdate":{"$t":"05/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1510665"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01668784"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510665/suppl_file/nejmoa1510665_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"11/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1P2zM4DRXAmWl_RLJs5PpxsTe2CkWSqE1vdPPNnmEWco/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"13/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Differences between protocol and registry entry."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"7"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"1"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1vFXq21LzlZkjL2DalVavgMjCbU_7A9VycpY0zO9vTwQ"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 18/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d6ua4"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"24"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa, publicationdate: 03/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2467551, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01146873, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 06/11/2015, completiondate: 08/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1Gfjvk5iTwWTI7WIt-_-Fl37V5PjpukTxNPVUCzpXISs/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/11/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 4, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 2, totalnumberofprespecifiedsecondaryoutcomes: 9, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1tSmxgXCEqNs_gvcx3A00rC1gCwFgWE6g7K9_HWlf56I/edit, lettercheckedbybgorch-initialanddate: BG 25/11, lettersubmissiondeadline: #REF!, lettersentdate: 06/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 9/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d6ua4"}],"gsx$studyid":{"$t":"24"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa"},"gsx$publicationdate":{"$t":"03/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2467551"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01146873"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"08/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1Gfjvk5iTwWTI7WIt-_-Fl37V5PjpukTxNPVUCzpXISs/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/11/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"9"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1tSmxgXCEqNs_gvcx3A00rC1gCwFgWE6g7K9_HWlf56I/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 25/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"06/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 9/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d88ul"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"25"},"content":{"type":"text","$t":"journalname: Ann Intern Med., trialtitle: Alexander Technique Lessons or Acupuncture Sessions for Persons With Chronic Neck Pain: A Randomized Trial, publicationdate: 03/11/2015, linktoonlinetrialreport: https://annals.org/article.aspx?articleid\u003d2467961, linktoonlinereistryentryfortrial: https://www.controlled-trials.com/ISRCTN15186354, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 06/11/2015, completiondate: 13/11/2015, linktoassessment: https://docs.google.com/open?authuser\u003dhenry.m.drysdale%40gmail.com\u0026id\u003d1qVmaNwxclrTtZzUh2YaecFj7bOIAIndvRSoRkHyQMBQ, assessmentcheckedbysecondassessor-date: 13/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 3, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 17, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 2, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1M_KNDBeSh4WVvWyz4nobpon4-LYGNNOlG-dXChChUTo/edit, lettercheckedbybgorch-initialanddate: BG 23 nov 15, lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter published, letterpublisheddate: 23/11/2015, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 3/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/d88ul"}],"gsx$studyid":{"$t":"25"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Ann Intern Med."},"gsx$trialtitle":{"$t":"Alexander Technique Lessons or Acupuncture Sessions for Persons With Chronic Neck Pain: A Randomized Trial"},"gsx$publicationdate":{"$t":"03/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://annals.org/article.aspx?articleid\u003d2467961"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.controlled-trials.com/ISRCTN15186354"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"13/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/open?authuser\u003dhenry.m.drysdale%40gmail.com\u0026id\u003d1qVmaNwxclrTtZzUh2YaecFj7bOIAIndvRSoRkHyQMBQ"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"13/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"17"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"2"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1M_KNDBeSh4WVvWyz4nobpon4-LYGNNOlG-dXChChUTo/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 23 nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"23/11/2015"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 3/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dkvya"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"26"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial, publicationdate: 07/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00068-9/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01030809, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 06/11/2015, completiondate: 12/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1rFEPRxKepvxmgBoSR4AB7LYE3hH47RnLAQ3PNoxjFaA, assessmentcheckedbysecondassessor-date: 17/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Where reporting of secondary outcomes is unclear. See assessment sheet comments , totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 3, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d19ol_bD43dNdXlUdoB2l9TBvkiTK4pIRRUryadFbPovI, lettercheckedbybgorch-initialanddate: KM 18/11, lettersubmissiondeadline: #REF!, lettersentdate: 19/11/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 22/12, complicationsandmattersarisinginfreetext: Endpoint was changed to 24 months in registry post trial commencement. Paper reports primary endpoint was at 12 months (so switched back). Some (insignificant) secondary outcome measures were only reported in the appendix."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dkvya"}],"gsx$studyid":{"$t":"26"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial"},"gsx$publicationdate":{"$t":"07/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00068-9/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01030809"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"12/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1rFEPRxKepvxmgBoSR4AB7LYE3hH47RnLAQ3PNoxjFaA"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"17/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Where reporting of secondary outcomes is unclear. See assessment sheet comments "},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d19ol_bD43dNdXlUdoB2l9TBvkiTK4pIRRUryadFbPovI"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 18/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"19/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 22/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Endpoint was changed to 24 months in registry post trial commencement. Paper reports primary endpoint was at 12 months (so switched back). Some (insignificant) secondary outcome measures were only reported in the appendix."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dmair"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"27"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial, publicationdate: 07/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00126-9/abstract, linktoonlinereistryentryfortrial: https://www.isrctn.com/ISRCTN37118456, linktopre-trialprotocolifavailable: Protocol published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 06/11/2015, completiondate: 13/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1zJXYlYwO7wEFpExAnQSevNKKzpQWS6hB9HMroTB3-ic, assessmentcheckedbysecondassessor-date: 17/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 14, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1w1FcU2f5GNsT41K8uFLKOZd2nc4GaD2AHoQGX5Gm67o, lettercheckedbybgorch-initialanddate: KM 18/11, lettersubmissiondeadline: #REF!, lettersentdate: 19/11/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 22/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dmair"}],"gsx$studyid":{"$t":"27"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial"},"gsx$publicationdate":{"$t":"07/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00126-9/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.isrctn.com/ISRCTN37118456"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Protocol published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"13/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1zJXYlYwO7wEFpExAnQSevNKKzpQWS6hB9HMroTB3-ic"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"17/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"14"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1w1FcU2f5GNsT41K8uFLKOZd2nc4GaD2AHoQGX5Gm67o"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 18/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"19/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 22/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dnp34"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"28"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial, publicationdate: 07/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00057-4/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT00267774, linktopre-trialprotocolifavailable: https://drive.google.com/file/d/0B7EgEnbh0CtLYWR6YkpRTEJBSGM/view , pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 06/11/2015, completiondate: 12/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1Tf7OfqrmVXQ-9UNq9Arvp0P3L7Q7aQhVF8CyjGQF6-8/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 15/11/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 5, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 1, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 5, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 1, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLbnk4NjdzTVRocWc/view, lettercheckedbybgorch-initialanddate: CH 18/11, lettersubmissiondeadline: #REF!, lettersentdate: 19/11/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 29/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dnp34"}],"gsx$studyid":{"$t":"28"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial"},"gsx$publicationdate":{"$t":"07/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00057-4/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT00267774"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLYWR6YkpRTEJBSGM/view "},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"12/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1Tf7OfqrmVXQ-9UNq9Arvp0P3L7Q7aQhVF8CyjGQF6-8/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"15/11/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"5"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"1"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLbnk4NjdzTVRocWc/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 18/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"19/11/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 29/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dp3nl"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"29"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial, publicationdate: 04/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00774-6/abstract, linktoonlinereistryentryfortrial: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 06/11/2015, completiondate: 16/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1ZHXt8oTW68mPzWbT18T_A0mZl0cuRPkcUeodFoiIx1c/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 17/11/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 3, totalnumberofprespecifiedsecondaryoutcomes: 1, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 16, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1tXYCsjXpTYIQi-fu6ch6rmPTe8z92I1dXML6jFe2S2U/edit, lettercheckedbybgorch-initialanddate: CH 17/11, lettersubmissiondeadline: #REF!, lettersentdate: 17/11/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dp3nl"}],"gsx$studyid":{"$t":"29"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial"},"gsx$publicationdate":{"$t":"04/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00774-6/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"16/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1ZHXt8oTW68mPzWbT18T_A0mZl0cuRPkcUeodFoiIx1c/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"17/11/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"16"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1tXYCsjXpTYIQi-fu6ch6rmPTe8z92I1dXML6jFe2S2U/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 17/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/11/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/df9om"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"30"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial, publicationdate: 04/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00515-2/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01848106, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 06/11/2015, completiondate: 08/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1C2pd7Glsr746SV0a6lrPPhibqxRyl0wpeNwLr_Cbcu8/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/11/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: Yes, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 0, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 21, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1KAqmC4lv5VdWN8tVx3q-01RebTsqg2U42r_rgUbKJRw/edit, lettercheckedbybgorch-initialanddate: CH 17/11, lettersubmissiondeadline: #REF!, lettersentdate: 17/11/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 20/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/df9om"}],"gsx$studyid":{"$t":"30"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial"},"gsx$publicationdate":{"$t":"04/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00515-2/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01848106"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"06/11/2015"},"gsx$completiondate":{"$t":"08/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1C2pd7Glsr746SV0a6lrPPhibqxRyl0wpeNwLr_Cbcu8/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/11/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"21"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1KAqmC4lv5VdWN8tVx3q-01RebTsqg2U42r_rgUbKJRw/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 17/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 20/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dgo93"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"31"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction, publicationdate: 08/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1510774, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT02053493, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510774/suppl_file/nejmoa1510774_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 13/11/2015, completiondate: 15/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1jCwJbak-f-nG4YQpCghJVVLJxU2Wdi2T0PtOys58iag, assessmentcheckedbysecondassessor-date: 16/11/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 8, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d120zGiRRUrabuUvvpDWwIx2Z9DYMEux7RsSIXWuTN9fg, lettercheckedbybgorch-initialanddate: KM 19/11, lettersubmissiondeadline: #REF!, lettersentdate: 19/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 22/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dgo93"}],"gsx$studyid":{"$t":"31"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction"},"gsx$publicationdate":{"$t":"08/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1510774"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT02053493"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510774/suppl_file/nejmoa1510774_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"15/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1jCwJbak-f-nG4YQpCghJVVLJxU2Wdi2T0PtOys58iag"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/11/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d120zGiRRUrabuUvvpDWwIx2Z9DYMEux7RsSIXWuTN9fg"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 19/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"19/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 22/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/di2tg"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"32"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: A Randomized Trial of Cardiovascular Responses to Energy Drink Consumption in Healthy Adults, publicationdate: 08/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469194, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01940822, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/data/Journals/JAMA/0/JLD150045supp1_prod.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 13/11/2015, completiondate: 15/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1JDSvQdt0ZQpTu3tkK_XpGtCOC8pxczkhUI-IZlgbWog/edit?usp\u003ddrive_web, assessmentcheckedbysecondassessor-date: 16/11/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 4, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 2, totalnumberofprespecifiedsecondaryoutcomes: 6, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 4, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1xV2ljGXrars-BlKiOMnWtxqkU8MLR9Etl_rlA_pQNag, lettercheckedbybgorch-initialanddate: BG 25 nov 15, lettersubmissiondeadline: #REF!, lettersentdate: 26/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 12/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/di2tg"}],"gsx$studyid":{"$t":"32"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"A Randomized Trial of Cardiovascular Responses to Energy Drink Consumption in Healthy Adults"},"gsx$publicationdate":{"$t":"08/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469194"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01940822"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/data/Journals/JAMA/0/JLD150045supp1_prod.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"15/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1JDSvQdt0ZQpTu3tkK_XpGtCOC8pxczkhUI-IZlgbWog/edit?usp\u003ddrive_web"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/11/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"6"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1xV2ljGXrars-BlKiOMnWtxqkU8MLR9Etl_rlA_pQNag"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 25 nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"26/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 12/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/djhdx"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"33"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction, publicationdate: 08/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469195, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01951625, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 13/11/2015, completiondate: 19/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1SsUx4ZZ1gYa06GdwsPH_hlH25fDgj7hU0TQI5bMxUqE/edit, assessmentcheckedbysecondassessor-date: 21/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 1, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 1, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 28, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 28, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: No, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLMW9nUDhINDIxZHM/view, lettercheckedbybgorch-initialanddate: CH 30/11, lettersubmissiondeadline: #REF!, lettersentdate: 03/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/djhdx"}],"gsx$studyid":{"$t":"33"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction"},"gsx$publicationdate":{"$t":"08/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469195"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01951625"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"19/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1SsUx4ZZ1gYa06GdwsPH_hlH25fDgj7hU0TQI5bMxUqE/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"21/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"28"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"28"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"No"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLMW9nUDhINDIxZHM/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 30/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"03/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dw4je"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"34"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial, publicationdate: 08/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00723-0/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT00531661, linktopre-trialprotocolifavailable: https://www.onlinejcf.com/article/S1071-9164(10)01049-3/abstract, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 13/11/2015, completiondate: 19/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1_0qc9LjkvawkuuTAem7dZjSjj4Ck8LMRcno2BFeQnks/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 21/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 0, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 0, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 8, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLMkFzVllubEY2djQ/view, lettercheckedbybgorch-initialanddate: CH 23/11, lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12, complicationsandmattersarisinginfreetext: Outcomes not entered into trial registry until after trial was completed. Protocol published after randomisation phase of trial was completed."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dw4je"}],"gsx$studyid":{"$t":"34"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial"},"gsx$publicationdate":{"$t":"08/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00723-0/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT00531661"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.onlinejcf.com/article/S1071-9164(10)01049-3/abstract"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"19/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1_0qc9LjkvawkuuTAem7dZjSjj4Ck8LMRcno2BFeQnks/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"21/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"8"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLMkFzVllubEY2djQ/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 23/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Outcomes not entered into trial registry until after trial was completed. Protocol published after randomisation phase of trial was completed."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dxj3v"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"35"},"content":{"type":"text","$t":"weekbeginning: 09/11/2015, journalname: NEJM, trialtitle: Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation, publicationdate: 09/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1512913, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT00807040, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512913/suppl_file/nejmoa1512913_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 13/11/2015, completiondate: 23/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1tunIl7eAGKvQinPtzHeP8CiwU9GglkH0seUnPN1cHe8/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 24/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: See comments in assessment sheet for secondaries 10 and 13, and non-prespecified 2, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 22, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 10, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLeEFQNUxlMU9lTGc/view, lettercheckedbybgorch-initialanddate: BG 30 nov, lettersubmissiondeadline: #REF!, lettersentdate: 30/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12, complicationsandmattersarisinginfreetext: State outcomes that cannot be found on the trial registry were pre-specified. Original protocol linked to the wrong trial but this has been corrected."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dxj3v"}],"gsx$studyid":{"$t":"35"},"gsx$weekbeginning":{"$t":"09/11/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1512913"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT00807040"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512913/suppl_file/nejmoa1512913_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"23/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1tunIl7eAGKvQinPtzHeP8CiwU9GglkH0seUnPN1cHe8/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"24/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"See comments in assessment sheet for secondaries 10 and 13, and non-prespecified 2"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"22"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"10"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLeEFQNUxlMU9lTGc/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 30 nov"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"30/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"State outcomes that cannot be found on the trial registry were pre-specified. Original protocol linked to the wrong trial but this has been corrected."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dyxo8"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"36"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Trial of Continuous or Interrupted Chest Compressions during CPR, publicationdate: 09/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1509139, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01372748?term\u003dNCT01372748\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509139/suppl_file/nejmoa1509139_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 13/11/2015, completiondate: 15/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1fsuathdpHeOBXEUlVR8L6hIz1QMaeuKFj9LCkWIaHq4/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 20/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 8, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 8, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 1, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1m3z1o4_ED4blEHxVsaxf9ta2XXWmYY9-PY82dR2dAtk/edit, lettercheckedbybgorch-initialanddate: CH 18/11, lettersubmissiondeadline: #REF!, lettersentdate: 18/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 20/12, complicationsandmattersarisinginfreetext: Mechanistic outcomes used in the protocol as a loop hole to 'allow' selective reporting of outcomes"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dyxo8"}],"gsx$studyid":{"$t":"36"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Trial of Continuous or Interrupted Chest Compressions during CPR"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1509139"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01372748?term\u003dNCT01372748\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509139/suppl_file/nejmoa1509139_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"15/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1fsuathdpHeOBXEUlVR8L6hIz1QMaeuKFj9LCkWIaHq4/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"20/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"8"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"1"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1m3z1o4_ED4blEHxVsaxf9ta2XXWmYY9-PY82dR2dAtk/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 18/11"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"18/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 20/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Mechanistic outcomes used in the protocol as a loop hole to 'allow' selective reporting of outcomes"}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e0c8p"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"37"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: A Randomized Trial of Intensive versus Standard Blood-Pressure Contro, publicationdate: 09/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1511939, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01206062?term\u003dNCT01206062\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1511939/suppl_file/nejmoa1511939_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 13/11/2015, completiondate: 22/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1c-i-kg9X1xA12DDCT_rjqYX8BOugcJj9T5hMNxN9Qt4/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 22/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 15, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 8, totalnumberofnon-prespecifiedoutcomesreported: 1, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1xF9GgmnIXDvoDTwuA9fajaxAD_Fjx-rKdyLoAdKeb8Q/edit, lettercheckedbybgorch-initialanddate: BG 23 nov 15, lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 20/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e0c8p"}],"gsx$studyid":{"$t":"37"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"A Randomized Trial of Intensive versus Standard Blood-Pressure Contro"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1511939"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01206062?term\u003dNCT01206062\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1511939/suppl_file/nejmoa1511939_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"22/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1c-i-kg9X1xA12DDCT_rjqYX8BOugcJj9T5hMNxN9Qt4/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"22/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"15"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"8"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"1"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1xF9GgmnIXDvoDTwuA9fajaxAD_Fjx-rKdyLoAdKeb8Q/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 23 nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 20/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dqi9q"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"38"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity, publicationdate: 09/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1510991, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT02207725?term\u003dNCT02207725\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510991/suppl_file/nejmoa1510991_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Eirion Slade, assigneddate: 13/11/2015, completiondate: 14/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1RkUwwOZotZEu8y8Fk-2r9PQ9cjZnOp4UpqqaE22yF7E, assessmentcheckedbysecondassessor-date: 24/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 4, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 4, totalnumberofprespecifiedsecondaryoutcomes: 16, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 8, numberofprespecifiedsecondaryoutcomescorrectlyreported: 8, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: No, finaldecision-letterrequired: No, linktoletter: No letter required, lettercheckedbybgorch-initialanddate: BG 25 nov 15, lettersubmissiondeadline: #REF!, lettersentdate: Not required, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 20/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dqi9q"}],"gsx$studyid":{"$t":"38"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1510991"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT02207725?term\u003dNCT02207725\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1510991/suppl_file/nejmoa1510991_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"14/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1RkUwwOZotZEu8y8Fk-2r9PQ9cjZnOp4UpqqaE22yF7E"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"24/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"4"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"16"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"8"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"No"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":"No letter required"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 25 nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"Not required"},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 20/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/drwu7"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"39"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease, publicationdate: 12/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1509038, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT01751906/2013_01_08, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509038/suppl_file/nejmoa1509038_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Eirion Slade, assigneddate: 13/11/2015, completiondate: 14/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1CBHSYsvqK5C1YztzA9L6i0o5KkbRG2zjoTpHIMz87uA/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 24/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Highlighted in yellow, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 83, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 15, totalnumberofnon-prespecifiedoutcomesreported: 8, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1eDeSFToRbaaz7y1WYFNUpHkpRO6rZPh6aiCXaCXZ_Ys/edit, lettercheckedbybgorch-initialanddate: BG 1dec15 (check 30 day 180day first), lettersubmissiondeadline: #REF!, lettersentdate: 02/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 9/01, complicationsandmattersarisinginfreetext: please check whether 30 and 180 day data has been reported, if not will need to code in scores here for them not reporting those time points"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/drwu7"}],"gsx$studyid":{"$t":"39"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease"},"gsx$publicationdate":{"$t":"12/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1509038"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT01751906/2013_01_08"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509038/suppl_file/nejmoa1509038_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"14/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1CBHSYsvqK5C1YztzA9L6i0o5KkbRG2zjoTpHIMz87uA/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"24/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Highlighted in yellow"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"83"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"15"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"8"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1eDeSFToRbaaz7y1WYFNUpHkpRO6rZPh6aiCXaCXZ_Ys/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 1dec15 (check 30 day 180day first)"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"02/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 9/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"please check whether 30 and 180 day data has been reported, if not will need to code in scores here for them not reporting those time points"}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dtbek"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"40"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of Financial Incentives to Physicians, Patients, or Both on Lipid LevelsA Randomized Clinical Trial, publicationdate: 10/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2468891, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01346189?term\u003dNCT01346189\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/data/Journals/JAMA/934661/JOI150135supp1_prod.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 13/11/2015, completiondate: 07/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1FziN7-JYsDe7ahysg6Z4RnXIyNhd8PMqCsYy94StHtU/edit, assessmentcheckedbysecondassessor-date: 24/11/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Reviewed by AD, who was then made first assessor, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 3, totalnumberofprespecifiedsecondaryoutcomes: 9, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLSjAxOTVaaVhYaVk/view, lettercheckedbybgorch-initialanddate: CH 8/12, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dtbek"}],"gsx$studyid":{"$t":"40"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of Financial Incentives to Physicians, Patients, or Both on Lipid LevelsA Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"10/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2468891"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01346189?term\u003dNCT01346189\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/data/Journals/JAMA/934661/JOI150135supp1_prod.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"07/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1FziN7-JYsDe7ahysg6Z4RnXIyNhd8PMqCsYy94StHtU/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"24/11/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Reviewed by AD, who was then made first assessor"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"9"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLSjAxOTVaaVhYaVk/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 8/12"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dupz1"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"41"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication, publicationdate: 10/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2468892, linktoonlinereistryentryfortrial: https://www.trialregister.nl/trialreg/admin/rctview.asp?TC\u003d2249, linktopre-trialprotocolifavailable: https://drive.google.com/file/d/0B2r5CjEdwpx_cWxzUFZOYXJHNG8/view, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 13/11/2015, completiondate: 22/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1eAkim6TDGpep4M2iILGn2wdUywyPD6zY5WCcW8pwBU4/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 02/12/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Resolved, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 3, totalnumberofprespecifiedsecondaryoutcomes: 37, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 21, totalnumberofnon-prespecifiedoutcomesreported: 6, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLSlpYal9QWjBZRVk/view, lettercheckedbybgorch-initialanddate: CH 8/12, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/dupz1"}],"gsx$studyid":{"$t":"41"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication"},"gsx$publicationdate":{"$t":"10/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2468892"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.trialregister.nl/trialreg/admin/rctview.asp?TC\u003d2249"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://drive.google.com/file/d/0B2r5CjEdwpx_cWxzUFZOYXJHNG8/view"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"22/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1eAkim6TDGpep4M2iILGn2wdUywyPD6zY5WCcW8pwBU4/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"02/12/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Resolved"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"37"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"21"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"6"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLSlpYal9QWjBZRVk/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 8/12"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e7d2q"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"42"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect ClosureThe CANOA Randomized Clinical Trial, publicationdate: 09/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469193, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT00799045, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/data/Journals/JAMA/0/JOI150131supp1_prod.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 13/11/2015, completiondate: 22/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1Gut8_L8TntvTvvla7w9Avl7tzGTlWuRhcejH7YAUYPw, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 8, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d11kO_lrV9jRmlFi1gIN6ORLoHhd0qgZH-lwKu8ZpTC4M, lettercheckedbybgorch-initialanddate: BG 7th dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 07/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 12/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e7d2q"}],"gsx$studyid":{"$t":"42"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect ClosureThe CANOA Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469193"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT00799045"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/data/Journals/JAMA/0/JOI150131supp1_prod.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"22/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1Gut8_L8TntvTvvla7w9Avl7tzGTlWuRhcejH7YAUYPw"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"8"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":""},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d11kO_lrV9jRmlFi1gIN6ORLoHhd0qgZH-lwKu8ZpTC4M"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 7th dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"07/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 12/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e8rn7"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"43"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent ImplantationThe IVUS-XPL Randomized Clinical Trial, publicationdate: 10/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469205, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01308281, linktopre-trialprotocolifavailable: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469205, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Henry Drysdale, assigneddate: 13/11/2015, completiondate: 16/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1JKogenf94xvPO3kT0oODQNOGmlAE_YdlHWioxLJwEbA/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 18/11/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 0, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 0, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 5, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1dEoWf4aNho7t2qBouhfgOZQRlPL46VjJPGtS7feXpcg/edit, lettercheckedbybgorch-initialanddate: BG 8th dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e8rn7"}],"gsx$studyid":{"$t":"43"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent ImplantationThe IVUS-XPL Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"10/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469205"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01308281"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469205"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"16/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1JKogenf94xvPO3kT0oODQNOGmlAE_YdlHWioxLJwEbA/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"18/11/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"5"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1dEoWf4aNho7t2qBouhfgOZQRlPL46VjJPGtS7feXpcg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 8th dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ea67k"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"44"},"content":{"type":"text","$t":"journalname: Ann Intern Med., trialtitle: Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial, publicationdate: 10/11/2015, linktoonlinetrialreport: https://annals.org/article.aspx?articleid\u003d2468807, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01909804, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 13/11/2015, completiondate: 17/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1C0T0fdhOOEXnlZ8UCBiuP2qlNtBh7ODFza1-CMjjd0o/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 18/11/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 3, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 5, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1XyX1ErKswep5i1tH2NNGDVVwpTXqGRM-Dfr_VlrMI0s/edit, lettercheckedbybgorch-initialanddate: BG 8th dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter published, letterpublisheddate: 08/12/2015, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 10/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ea67k"}],"gsx$studyid":{"$t":"44"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Ann Intern Med."},"gsx$trialtitle":{"$t":"Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial"},"gsx$publicationdate":{"$t":"10/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://annals.org/article.aspx?articleid\u003d2468807"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01909804"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"17/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1C0T0fdhOOEXnlZ8UCBiuP2qlNtBh7ODFza1-CMjjd0o/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"18/11/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"5"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1XyX1ErKswep5i1tH2NNGDVVwpTXqGRM-Dfr_VlrMI0s/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 8th dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"08/12/2015"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 10/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ebks1"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"45"},"content":{"type":"text","$t":"journalname: Ann Intern Med., trialtitle: Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial, publicationdate: 10/11/2015, linktoonlinetrialreport: https://annals.org/article.aspx?articleid\u003d2468806, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01858766, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 13/11/2015, completiondate: 18/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/18_bZ5IUB3OTJPf2vP15sCgI15ZBtFvfR9UTs1TFPVKQ/edit#gid\u003d0, secondassessorname: Eirion Slade, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: I agree that pharmacokinetics is inadequately prespecified, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 5, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1r8gSIkQJn9XK5BPr6QQun3HbOONiWnXeZ_RX878kwFQ/edit, lettercheckedbybgorch-initialanddate: BG 8th dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter published, letterpublisheddate: 08/12/2015, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 10/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ebks1"}],"gsx$studyid":{"$t":"45"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Ann Intern Med."},"gsx$trialtitle":{"$t":"Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial"},"gsx$publicationdate":{"$t":"10/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://annals.org/article.aspx?articleid\u003d2468806"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01858766"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"18/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/18_bZ5IUB3OTJPf2vP15sCgI15ZBtFvfR9UTs1TFPVKQ/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"I agree that pharmacokinetics is inadequately prespecified"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1r8gSIkQJn9XK5BPr6QQun3HbOONiWnXeZ_RX878kwFQ/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 8th dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"08/12/2015"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 10/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e1qt2"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"46"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial, publicationdate: 09/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00724-2/abstract, linktoonlinereistryentryfortrial: https://www.isrctn.com/ISRCTN44485060, linktopre-trialprotocolifavailable: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464097/, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Ioan Milosevic, assigneddate: 13/11/2015, completiondate: 19/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1EELYPdHYa2mD2VTJiSDcOUeqrHLNPZu6RvrtWMucDRg, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 34, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 5, numberofprespecifiedsecondaryoutcomescorrectlyreported: 11, totalnumberofnon-prespecifiedoutcomesreported: 17, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1RIqokpmY0f6e6faqyFtIX0DAjoIImN5EbXqg01Hv7iU, lettercheckedbybgorch-initialanddate: BG 23 nov 15, lettersubmissiondeadline: #REF!, lettersentdate: 23/11/2015, letterstatus: Letter published, letterpublisheddate: 14/05/2016, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 22/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e1qt2"}],"gsx$studyid":{"$t":"46"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial"},"gsx$publicationdate":{"$t":"09/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00724-2/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.isrctn.com/ISRCTN44485060"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464097/"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"19/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1EELYPdHYa2mD2VTJiSDcOUeqrHLNPZu6RvrtWMucDRg"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"34"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"11"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"17"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":""},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1RIqokpmY0f6e6faqyFtIX0DAjoIImN5EbXqg01Hv7iU"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 23 nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"23/11/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"14/05/2016"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 22/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e35dj"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"47"},"content":{"type":"text","$t":"journalname: BMJ, trialtitle: Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial, publicationdate: 11/11/2015, linktoonlinetrialreport: https://www.bmj.com/content/351/bmj.h5627, linktoonlinereistryentryfortrial: https://www.isrctn.com/ISRCTN91947481?q\u003d91947481\u0026filters\u003d\u0026sort\u003d\u0026offset\u003d1\u0026totalResults\u003d1\u0026page\u003d1\u0026pageSize\u003d10\u0026searchType\u003dbasic-search, linktopre-trialprotocolifavailable: Published after trial start date, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 13/11/2015, completiondate: 19/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1_9VL-TCvAKN57HB8D_WQVNptMDRM7wihuLtRDO37Lyg/edit#gid\u003d0, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1VjFAe7Hb0ZjkKCprmphTPLNX4Sp8MHZKn4PH5ICLQNs/edit, lettercheckedbybgorch-initialanddate: KM 17/12, lettersubmissiondeadline: BMJ, lettersentdate: 17/12/2015, letterstatus: Letter published, letterpublisheddate: 17/12/2015, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 17/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e35dj"}],"gsx$studyid":{"$t":"47"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"BMJ"},"gsx$trialtitle":{"$t":"Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial"},"gsx$publicationdate":{"$t":"11/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.bmj.com/content/351/bmj.h5627"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.isrctn.com/ISRCTN91947481?q\u003d91947481\u0026filters\u003d\u0026sort\u003d\u0026offset\u003d1\u0026totalResults\u003d1\u0026page\u003d1\u0026pageSize\u003d10\u0026searchType\u003dbasic-search"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Published after trial start date"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"13/11/2015"},"gsx$completiondate":{"$t":"19/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1_9VL-TCvAKN57HB8D_WQVNptMDRM7wihuLtRDO37Lyg/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1VjFAe7Hb0ZjkKCprmphTPLNX4Sp8MHZKn4PH5ICLQNs/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 17/12"},"gsx$lettersubmissiondeadline":{"$t":"BMJ"},"gsx$lettersentdate":{"$t":"17/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"17/12/2015"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 17/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e4jxw"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"48"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial, publicationdate: 13/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2469891, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01489189, linktopre-trialprotocolifavailable: https://drive.google.com/file/d/0B7EgEnbh0CtLV0VESlJtdnp6TXc/view, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 14/11/2015, completiondate: 09/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1guirfvsEo-p5s4paPc4a2H9N4vnZmg_jAty4k3HRSWs/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 09/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 13, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 10, totalnumberofnon-prespecifiedoutcomesreported: 16, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLcjdEM2JrMkxXcjg/view, lettercheckedbybgorch-initialanddate: BG 9 dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 09/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 10/01/16"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e4jxw"}],"gsx$studyid":{"$t":"48"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial"},"gsx$publicationdate":{"$t":"13/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2469891"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01489189"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLV0VESlJtdnp6TXc/view"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"14/11/2015"},"gsx$completiondate":{"$t":"09/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1guirfvsEo-p5s4paPc4a2H9N4vnZmg_jAty4k3HRSWs/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"09/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"13"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"10"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"16"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLcjdEM2JrMkxXcjg/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9 dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 10/01/16"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e5yid"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"49"},"content":{"type":"text","$t":"weekbeginning: 16/11/2015, journalname: NEJM, trialtitle: Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection, publicationdate: 16/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1512610, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT02201940, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 20/11/2015, completiondate: 26/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1nccs4wi1NVQyEum-_iNIqU1YAHTqSY3DS68NuaDBY04/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 30/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 5, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 1, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1YvUqNW7sXhaWFTd4iQhrD6dVbfc3NCHZcKVowbXwZUM/edit, lettercheckedbybgorch-initialanddate: bg 30 nov 2015, lettersubmissiondeadline: #REF!, lettersentdate: 30/11/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 31/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/e5yid"}],"gsx$studyid":{"$t":"49"},"gsx$weekbeginning":{"$t":"16/11/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection"},"gsx$publicationdate":{"$t":"16/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1512610"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT02201940"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"26/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1nccs4wi1NVQyEum-_iNIqU1YAHTqSY3DS68NuaDBY04/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"30/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":""},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1YvUqNW7sXhaWFTd4iQhrD6dVbfc3NCHZcKVowbXwZUM/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"bg 30 nov 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"30/11/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 31/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eilm2"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"50"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis, publicationdate: 16/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1512614, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT02201901, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512614/suppl_file/nejmoa1512614_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 20/11/2015, completiondate: 27/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/15HctRRJgbzT6LudoICPAoKqP8XYNMUkTpjzpS4r449E/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 02/11/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomescorrectlyreported: 2, totalnumberofprespecifiedsecondaryoutcomes: 7, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 1, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1n964-B-uy9D3NMDsHaIUfJICwo0RL_JqVS2Wu-iipMg/edit, lettercheckedbybgorch-initialanddate: BG 7 dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 07/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eilm2"}],"gsx$studyid":{"$t":"50"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis"},"gsx$publicationdate":{"$t":"16/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1512614"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT02201901"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512614/suppl_file/nejmoa1512614_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"27/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/15HctRRJgbzT6LudoICPAoKqP8XYNMUkTpjzpS4r449E/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"02/11/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"7"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1n964-B-uy9D3NMDsHaIUfJICwo0RL_JqVS2Wu-iipMg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 7 dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"07/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ek06j"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"51A"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection, publicationdate: 17/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1512612, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/results?term\u003dNCT02220998\u0026Search\u003dSearch, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512612/suppl_file/nejmoa1512612_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 20/11/2015, completiondate: 26/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1DDCeC1a1aYHWJYjIFwV8gJq4rj50nqyGDWRQ7KcSmzY/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 28/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Use endpoints, not objectives, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 5, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/19_0GAMa0PY4tl4FTUvlGOSn7_v_JsEQ10Jmk5TXpNcI/edit, lettercheckedbybgorch-initialanddate: CH 8/12, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 9/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ek06j"}],"gsx$studyid":{"$t":"51A"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection"},"gsx$publicationdate":{"$t":"17/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1512612"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/results?term\u003dNCT02220998\u0026Search\u003dSearch"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512612/suppl_file/nejmoa1512612_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"26/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1DDCeC1a1aYHWJYjIFwV8gJq4rj50nqyGDWRQ7KcSmzY/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"28/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Use endpoints, not objectives"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/19_0GAMa0PY4tl4FTUvlGOSn7_v_JsEQ10Jmk5TXpNcI/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 8/12"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 9/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eleqw"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"51B"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection, publicationdate: 17/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1512612, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/results?term\u003dNCT02220998\u0026Search\u003dSearch, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512612/suppl_file/nejmoa1512612_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 20/11/2015, completiondate: 26/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1njT04nYNQprKTQmR0qRTX6B434Npy-00f97FlSA1cus/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 28/11/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Use endpoints, not objectives, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 5, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 2, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/19_0GAMa0PY4tl4FTUvlGOSn7_v_JsEQ10Jmk5TXpNcI/edit, lettercheckedbybgorch-initialanddate: CH 8/12, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 9/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eleqw"}],"gsx$studyid":{"$t":"51B"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection"},"gsx$publicationdate":{"$t":"17/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1512612"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/results?term\u003dNCT02220998\u0026Search\u003dSearch"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1512612/suppl_file/nejmoa1512612_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"26/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1njT04nYNQprKTQmR0qRTX6B434Npy-00f97FlSA1cus/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"28/11/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Use endpoints, not objectives"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"5"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"2"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/19_0GAMa0PY4tl4FTUvlGOSn7_v_JsEQ10Jmk5TXpNcI/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 8/12"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 9/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/emtbd"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"52"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study, publicationdate: 19/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1413275, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT02094365?term\u003dNCT02094365\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1413275/suppl_file/nejmoa1413275_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 20/11/2015, completiondate: 28/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1MVihr8u2QI5YjGPqpwucxFI-20c9x2OnGV_PGsqtRaM/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 03/12/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Query on some endpoints, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 11, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 7, totalnumberofnon-prespecifiedoutcomesreported: 5, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1pX_tVdwisSJdRgzlE3RlR_wFLYNpdelvHaGPFDjm7cU/edit, lettercheckedbybgorch-initialanddate: bg 9 dec 2015, lettersubmissiondeadline: #REF!, lettersentdate: 09/12/2012, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: PH 6/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/emtbd"}],"gsx$studyid":{"$t":"52"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study"},"gsx$publicationdate":{"$t":"19/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1413275"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT02094365?term\u003dNCT02094365\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1413275/suppl_file/nejmoa1413275_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"28/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1MVihr8u2QI5YjGPqpwucxFI-20c9x2OnGV_PGsqtRaM/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"03/12/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Query on some endpoints"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"11"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"7"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"5"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1pX_tVdwisSJdRgzlE3RlR_wFLYNpdelvHaGPFDjm7cU/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"bg 9 dec 2015"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/12/2012"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"PH 6/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eczce"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"53"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk, publicationdate: 19/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1503943, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01623180?term\u003dNCT01623180\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1503943/suppl_file/nejmoa1503943_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 20/11/2015, completiondate: 27/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/10j0IMnvKDcc-y3BkzDtN9QtRpOXkTSNLhNsGeiSjGp0/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 09/12/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: https://drive.google.com/open?id\u003d1tNBJpxaBJ2zfDfHXCK6RDCxrrtCRxsfqw1SWKg1efVY, totalnumberofprespecifiedprimaryoutcomes: 2, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 2, totalnumberofprespecifiedsecondaryoutcomes: 55, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 11, totalnumberofnon-prespecifiedoutcomesreported: 10, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1ws7dVAywuPhIau7SvrjUlRqwKKMJY-IDw9QauoEVrGc/edit, lettercheckedbybgorch-initialanddate: BG 9th dec 2015 but update refs and discuss with ioan, lettersubmissiondeadline: #REF!, lettersentdate: 09/12/2012, letterstatus: Letter rejected by editor"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eczce"}],"gsx$studyid":{"$t":"53"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk"},"gsx$publicationdate":{"$t":"19/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1503943"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01623180?term\u003dNCT01623180\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1503943/suppl_file/nejmoa1503943_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"27/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/10j0IMnvKDcc-y3BkzDtN9QtRpOXkTSNLhNsGeiSjGp0/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"09/12/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"https://drive.google.com/open?id\u003d1tNBJpxaBJ2zfDfHXCK6RDCxrrtCRxsfqw1SWKg1efVY"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"2"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"55"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"11"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"10"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":""},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1ws7dVAywuPhIau7SvrjUlRqwKKMJY-IDw9QauoEVrGc/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 9th dec 2015 but update refs and discuss with ioan"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/12/2012"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":""},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eedwv"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"54"},"content":{"type":"text","$t":"journalname: JAMA, trialtitle: Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses, publicationdate: 17/11/2015, linktoonlinetrialreport: https://jama.jamanetwork.com/article.aspx?articleid\u003d2470445, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01272635, linktopre-trialprotocolifavailable: Published after trial commencement, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 20/11/2015, completiondate: 22/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1sS5CEggFn41gaUErP6ErIX0UVdXVOyFz5VVE-caHlFg, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d13fMOwWRXHO1AsTDm7sylMFgB8raJbe-y8UOodCXrpJM, lettercheckedbybgorch-initialanddate: BG 14th dec, lettersubmissiondeadline: #REF!, lettersentdate: 15/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 12/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eedwv"}],"gsx$studyid":{"$t":"54"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"JAMA"},"gsx$trialtitle":{"$t":"Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses"},"gsx$publicationdate":{"$t":"17/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://jama.jamanetwork.com/article.aspx?articleid\u003d2470445"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01272635"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Published after trial commencement"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"22/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1sS5CEggFn41gaUErP6ErIX0UVdXVOyFz5VVE-caHlFg"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d13fMOwWRXHO1AsTDm7sylMFgB8raJbe-y8UOodCXrpJM"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 14th dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"15/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 12/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/efsh8"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"55"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial, publicationdate: 18/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00984-8/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT00640263, linktopre-trialprotocolifavailable: Published after trial commencement, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 20/11/2015, completiondate: 22/11/2015, linktoassessment: https://drive.google.com/open?id\u003d1Bxlh5UFaCzUKMzvASWJX6T3AUhArKBqcv2wdpJK-TJI, secondassessorname: Eirion Slade, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 4, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 2, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: No, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: BG 25 Nov 15, lettersubmissiondeadline: #REF!, lettersentdate: Not required, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 12/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/efsh8"}],"gsx$studyid":{"$t":"55"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial"},"gsx$publicationdate":{"$t":"18/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00984-8/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT00640263"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Published after trial commencement"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"22/11/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1Bxlh5UFaCzUKMzvASWJX6T3AUhArKBqcv2wdpJK-TJI"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"4"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"2"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"No"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 25 Nov 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"Not required"},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 12/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eh71p"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"56"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study, publicationdate: 19/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00803-X/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT01237119, linktopre-trialprotocolifavailable: https://bmjopen.bmj.com/content/3/11/e003995.full.pdf+html, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 20/11/2015, completiondate: 30/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1xV7Fq9i8RC9IecqVf71gcQhqhXynU__3FcSyYAzRL64/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 12/12/2015, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 18, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 16, totalnumberofnon-prespecifiedoutcomesreported: 4, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLTElKSVVjWHNuNmc/view, lettercheckedbybgorch-initialanddate: CH 30 Nov 25, lettersubmissiondeadline: #REF!, lettersentdate: 03/12/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eh71p"}],"gsx$studyid":{"$t":"56"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study"},"gsx$publicationdate":{"$t":"19/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00803-X/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT01237119"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://bmjopen.bmj.com/content/3/11/e003995.full.pdf+html"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"30/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1xV7Fq9i8RC9IecqVf71gcQhqhXynU__3FcSyYAzRL64/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"12/12/2015"},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"18"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"16"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"4"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLTElKSVVjWHNuNmc/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 30 Nov 25"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"03/12/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/etu5e"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"57"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial, publicationdate: 21/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00257-3/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT02369081, linktopre-trialprotocolifavailable: Published after trial completion, assessorname: Aaron Dale, assigneddate: 20/11/2015, completiondate: 02/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1i6m6KCrN8B3W2HjNDqLy4ztYw8o8TTvVCGZP5qeMC8I/edit#gid\u003d0\u0026vpid\u003dA1, secondassessorname: Philip Hartley, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 1, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 10, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/file/d/0B7EgEnbh0CtLNXRiUWxTV3BZeFk/view, lettercheckedbybgorch-initialanddate: BG 4 Dec 15 but correct refs and get phil approval, lettersubmissiondeadline: #REF!, lettersentdate: 05/12/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 10/01/16, complicationsandmattersarisinginfreetext: Registry entry not made until four months before final data collection. Protocol not published until after final data collection. EudraCT registry entry not acccessible."},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/etu5e"}],"gsx$studyid":{"$t":"57"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial"},"gsx$publicationdate":{"$t":"21/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00257-3/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT02369081"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Published after trial completion"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":""},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"02/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1i6m6KCrN8B3W2HjNDqLy4ztYw8o8TTvVCGZP5qeMC8I/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Philip Hartley"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"10"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":""},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/file/d/0B7EgEnbh0CtLNXRiUWxTV3BZeFk/view"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4 Dec 15 but correct refs and get phil approval"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"05/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 10/01/16"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":"Registry entry not made until four months before final data collection. Protocol not published until after final data collection. EudraCT registry entry not acccessible."}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ev8pv"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"58"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial, publicationdate: 21/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00244-5/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT01629550/2012_06_29, linktopre-trialprotocolifavailable: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680971/pdf/1745-6215-14-114.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 20/11/2015, completiondate: 24/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1WHdJz_Y94HiYOhEA7QFr3MqrTdgmuemVf1UYpa9Zoa4/edit, assessmentcheckedbysecondassessor-date: 30/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: See comments on assessment sheet. Have deleted NPS outcomes for now, as I think it would help to re-assess these., totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 7, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 6, totalnumberofnon-prespecifiedoutcomesreported: 1, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 1, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: BG 4 Dec 15 no letter required on balance, list of prespecified outcomes in paper so implicit that outcomes not in that list are non pre specified, and mortality/hospital stay issues discussed in comments on sheet.  , lettersubmissiondeadline: #REF!, lettersentdate: Not required, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 31/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ev8pv"}],"gsx$studyid":{"$t":"58"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial"},"gsx$publicationdate":{"$t":"21/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00244-5/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT01629550/2012_06_29"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680971/pdf/1745-6215-14-114.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"24/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1WHdJz_Y94HiYOhEA7QFr3MqrTdgmuemVf1UYpa9Zoa4/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"30/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"See comments on assessment sheet. Have deleted NPS outcomes for now, as I think it would help to re-assess these."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"7"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"6"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"1"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"1"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4 Dec 15 no letter required on balance, list of prespecified outcomes in paper so implicit that outcomes not in that list are non pre specified, and mortality/hospital stay issues discussed in comments on sheet.  "},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"Not required"},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 31/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ewna8"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"59"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial, publicationdate: 21/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00239-1/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT01304524/2012_04_06, linktopre-trialprotocolifavailable: https://docs.google.com/document/d/119m4R_9yolR5UirEAbUfy37pHtYhS8cIHK1y_uWiFpE/edit, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 20/11/2015, completiondate: 24/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/14ktLgb_5lY1_dmhtbjc8W5Q0KH3NlTKH6FWptjFDZLs/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 30/11/2015, secondassessorname: Henry Drysdale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: See comments on assessment sheet. Consider including NPS for all results given with p-values in free text results section. These are highlighted in the pdf that's saved in the Trial 59 folder, but have not been included yet., totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 1, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 1, totalnumberofnon-prespecifiedoutcomesreported: 15, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 15, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: No, lettercheckedbybgorch-initialanddate: BG 4 DEc 15 overall no letter, lettersubmissiondeadline: #REF!, lettersentdate: Not required, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 31/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ewna8"}],"gsx$studyid":{"$t":"59"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial"},"gsx$publicationdate":{"$t":"21/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00239-1/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT01304524/2012_04_06"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://docs.google.com/document/d/119m4R_9yolR5UirEAbUfy37pHtYhS8cIHK1y_uWiFpE/edit"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"20/11/2015"},"gsx$completiondate":{"$t":"24/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/14ktLgb_5lY1_dmhtbjc8W5Q0KH3NlTKH6FWptjFDZLs/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"30/11/2015"},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"See comments on assessment sheet. Consider including NPS for all results given with p-values in free text results section. These are highlighted in the pdf that's saved in the Trial 59 folder, but have not been included yet."},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"15"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"15"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":""},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 4 DEc 15 overall no letter"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"Not required"},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 31/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ey1up"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"60"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial , publicationdate: 29/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00986-1/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01494506, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Ioan Milosevic, assigneddate: 27/11/2015, completiondate: 08/12/2015, linktoassessment: https://drive.google.com/open?id\u003d1qsbm-_M5ORh-a452xMV015-3R-IrPOZkuI4Kglx-M0A, secondassessorname: Henry Drysdale, secondassessordiscrepancies: No, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 3, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1fpbgK51Vhl0BH5l0TTl2GP37e-QVhUQYQbH8gpyPw7I/edit, lettercheckedbybgorch-initialanddate: BG 8th dec 15, lettersubmissiondeadline: #REF!, lettersentdate: 09/12/2015, letterstatus: Letter published, letterpublisheddate: 14/05/2016, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: IM 12/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/ey1up"}],"gsx$studyid":{"$t":"60"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial "},"gsx$publicationdate":{"$t":"29/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00986-1/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01494506"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Ioan Milosevic"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"08/12/2015"},"gsx$linktoassessment":{"$t":"https://drive.google.com/open?id\u003d1qsbm-_M5ORh-a452xMV015-3R-IrPOZkuI4Kglx-M0A"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Henry Drysdale"},"gsx$secondassessordiscrepancies":{"$t":"No"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1fpbgK51Vhl0BH5l0TTl2GP37e-QVhUQYQbH8gpyPw7I/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 8th dec 15"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"09/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"14/05/2016"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"IM 12/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eo7vq"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"62"},"content":{"type":"text","$t":"weekbeginning: 23/11/2015, journalname: NEJM, trialtitle: A Randomized Trial of Progesterone in Women with Recurrent Miscarriages, publicationdate: 26/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1504927, linktoonlinereistryentryfortrial: https://www.controlled-trials.com/ISRCTN92644181, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/full/10.1056/NEJMoa1504927, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Aaron Dale, assigneddate: 27/11/2015, completiondate: 12/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1CThX2yhqwjNwWGJtSmuHtGtRAtMrw0XbdMdJ4D5Siks/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 12/12/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Resolved, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 8, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 8, totalnumberofnon-prespecifiedoutcomesreported: 0, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: No, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: No, linktoletter: Letter not required, lettercheckedbybgorch-initialanddate: BG 14th dec, lettersubmissiondeadline: #REF!, lettersentdate: Not required, letterstatus: Letter not required, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: AD 30/12"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/eo7vq"}],"gsx$studyid":{"$t":"62"},"gsx$weekbeginning":{"$t":"23/11/2015"},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"A Randomized Trial of Progesterone in Women with Recurrent Miscarriages"},"gsx$publicationdate":{"$t":"26/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1504927"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.controlled-trials.com/ISRCTN92644181"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1504927"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"12/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1CThX2yhqwjNwWGJtSmuHtGtRAtMrw0XbdMdJ4D5Siks/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"12/12/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Resolved"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"8"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"8"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"0"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"No"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"No"},"gsx$linktoletter":{"$t":"Letter not required"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 14th dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"Not required"},"gsx$letterstatus":{"$t":"Letter not required"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"AD 30/12"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/epmg7"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"63"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes, publicationdate: 26/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1504720, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/NCT01131676?term\u003dNCT01131676\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1504720/suppl_file/nejmoa1504720_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 27/11/2015, completiondate: 12/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/12R5h3ccCaSdO6ZS-yRmw4GQQ-D1-rmqJfb-rDi6IxM4/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/12/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Just check HbA1c as a NPS and also hospitalisation for unstable angina is a component of the primary outcome. Also just check that the Registry enty used tallies up to the original protocol outcomes (which can be deduced by looking through the summary of changes), totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 50, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 36, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1oY24c8cC7sn5pH51T4ITm0XbL_B5xXJSGt2-LdzhSpM/edit, lettercheckedbybgorch-initialanddate: BG 17 dec, lettersubmissiondeadline: #REF!, lettersentdate: 17/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 12/1"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/epmg7"}],"gsx$studyid":{"$t":"63"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes"},"gsx$publicationdate":{"$t":"26/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1504720"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/NCT01131676?term\u003dNCT01131676\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1504720/suppl_file/nejmoa1504720_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"12/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/12R5h3ccCaSdO6ZS-yRmw4GQQ-D1-rmqJfb-rDi6IxM4/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/12/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Just check HbA1c as a NPS and also hospitalisation for unstable angina is a component of the primary outcome. Also just check that the Registry enty used tallies up to the original protocol outcomes (which can be deduced by looking through the summary of changes)"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"50"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"36"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1oY24c8cC7sn5pH51T4ITm0XbL_B5xXJSGt2-LdzhSpM/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 17 dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 12/1"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/er10k"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"64A"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Home Use of an Artificial Beta Cell in Type 1 Diabetes in Adults, publicationdate: 26/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1509351, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01961622?term\u003dNCT01961622\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509351/suppl_file/nejmoa1509351_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 27/11/2015, completiondate: 16/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1jGHHRB0iztdonRgavgPEh1tvR9mgwQ0Jqo42VrNVrkA/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/12/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: Yes, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 15, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 10, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1P-NdVGnMym6yRJNzYLRDRjEBfCPv88KcmPxRrfozURg/edit, lettercheckedbybgorch-initialanddate: BG 17 dec, lettersubmissiondeadline: #REF!, lettersentdate: 17/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/er10k"}],"gsx$studyid":{"$t":"64A"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Home Use of an Artificial Beta Cell in Type 1 Diabetes in Adults"},"gsx$publicationdate":{"$t":"26/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1509351"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01961622?term\u003dNCT01961622\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509351/suppl_file/nejmoa1509351_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"16/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1jGHHRB0iztdonRgavgPEh1tvR9mgwQ0Jqo42VrNVrkA/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/12/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"15"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"10"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1P-NdVGnMym6yRJNzYLRDRjEBfCPv88KcmPxRrfozURg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 17 dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/esfl1"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"64B"},"content":{"type":"text","$t":"journalname: NEJM, trialtitle: Home Use of an Artificial Beta Cell in Type 1 Diabetes in Children, publicationdate: 26/11/2015, linktoonlinetrialreport: https://www.nejm.org/doi/full/10.1056/NEJMoa1509351, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/ct2/show/record/NCT01961622?term\u003dNCT01961622\u0026rank\u003d1, linktopre-trialprotocolifavailable: https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509351/suppl_file/nejmoa1509351_protocol.pdf, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Protocol, assessorname: Philip Hartley, assigneddate: 27/11/2015, completiondate: 16/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1GMdsMzOTXTdTCi84WsUoz0VfKT96Ki6QAoA8z1nRLg4/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/12/2015, secondassessorname: Eirion Slade, secondassessordiscrepancies: Yes, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 12, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 8, totalnumberofnon-prespecifiedoutcomesreported: 4, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1P-NdVGnMym6yRJNzYLRDRjEBfCPv88KcmPxRrfozURg/edit, lettercheckedbybgorch-initialanddate: BG 17 dec, lettersubmissiondeadline: #REF!, lettersentdate: 17/12/2015, letterstatus: Letter rejected by editor, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/esfl1"}],"gsx$studyid":{"$t":"64B"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"NEJM"},"gsx$trialtitle":{"$t":"Home Use of an Artificial Beta Cell in Type 1 Diabetes in Children"},"gsx$publicationdate":{"$t":"26/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.nejm.org/doi/full/10.1056/NEJMoa1509351"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/ct2/show/record/NCT01961622?term\u003dNCT01961622\u0026rank\u003d1"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.nejm.org/doi/suppl/10.1056/NEJMoa1509351/suppl_file/nejmoa1509351_protocol.pdf"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Protocol"},"gsx$assessorname":{"$t":"Philip Hartley"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"16/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1GMdsMzOTXTdTCi84WsUoz0VfKT96Ki6QAoA8z1nRLg4/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/12/2015"},"gsx$secondassessorname":{"$t":"Eirion Slade"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"12"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"8"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"4"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1P-NdVGnMym6yRJNzYLRDRjEBfCPv88KcmPxRrfozURg/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 17 dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"17/12/2015"},"gsx$letterstatus":{"$t":"Letter rejected by editor"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a59y2"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"68"},"content":{"type":"text","$t":"journalname: Ann Intern Med., trialtitle: HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors, publicationdate: 24/11/2015, linktoonlinetrialreport: https://annals.org/article.aspx?articleid\u003d2471595, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/archive/NCT00537394/2008_01_28, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 27/11/2015, completiondate: 15/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1yxheOx7lrvK0wejwoFbiYyso4DBcHh3-3HJIqrFXYgc/edit#gid\u003d0, assessmentcheckedbysecondassessor-date: 16/12/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: Comments on powerpoint and assessment sheet, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 22, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 1, numberofprespecifiedsecondaryoutcomescorrectlyreported: 7, totalnumberofnon-prespecifiedoutcomesreported: 3, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1ME1gndvrt1_ZZ49QJ1nnkpsX4900V8gCuRRSRfyj0Ys/edit, lettersubmissiondeadline: #REF!, lettersentdate: 22/12/2015, letterstatus: Letter published, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a59y2"}],"gsx$studyid":{"$t":"68"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Ann Intern Med."},"gsx$trialtitle":{"$t":"HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors"},"gsx$publicationdate":{"$t":"24/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://annals.org/article.aspx?articleid\u003d2471595"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/archive/NCT00537394/2008_01_28"},"gsx$linktopre-trialprotocolifavailable":{"$t":""},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"15/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1yxheOx7lrvK0wejwoFbiYyso4DBcHh3-3HJIqrFXYgc/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/12/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"Comments on powerpoint and assessment sheet"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"22"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"1"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"7"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"3"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1ME1gndvrt1_ZZ49QJ1nnkpsX4900V8gCuRRSRfyj0Ys/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":""},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"22/12/2015"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a6oij"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"69"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial, publicationdate: 25/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01027-2/abstract, linktoonlinereistryentryfortrial: https://www.controlled-trials.com/ISRCTN05511098?q\u003d05511098\u0026filters\u003d\u0026sort\u003d\u0026offset\u003d1\u0026totalResults\u003d1\u0026page\u003d1\u0026pageSize\u003d10\u0026searchType\u003dbasic-search, linktopre-trialprotocolifavailable: https://www.npeu.ox.ac.uk/PiPS/protocol (only available registry entries and protocol available after start date, but both identical so registry entry (easier) used), pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Eirion Slade, assigneddate: 27/11/2015, completiondate: 07/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1fdBEsYbFGZsS7YkX6-3g_7uSklWrp3YpHM13-Cf9kBs/edit, assessmentcheckedbysecondassessor-date: 07/12/2015, secondassessorname: Aaron Dale, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: See comments sheet, totalnumberofprespecifiedprimaryoutcomes: 3, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 3, totalnumberofprespecifiedsecondaryoutcomes: 19, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 18, totalnumberofnon-prespecifiedoutcomesreported: 8, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1UjJ9lDW5oDFILb6VoiUOzTaH0-Gi-QVnibpnhjydXxE/edit, lettercheckedbybgorch-initialanddate: KM 8/12, lettersubmissiondeadline: #REF!, lettersentdate: 08/12/2015, letterstatus: Letter unpublished after 4 weeks, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: ES 09/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a6oij"}],"gsx$studyid":{"$t":"69"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial"},"gsx$publicationdate":{"$t":"25/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01027-2/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.controlled-trials.com/ISRCTN05511098?q\u003d05511098\u0026filters\u003d\u0026sort\u003d\u0026offset\u003d1\u0026totalResults\u003d1\u0026page\u003d1\u0026pageSize\u003d10\u0026searchType\u003dbasic-search"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.npeu.ox.ac.uk/PiPS/protocol (only available registry entries and protocol available after start date, but both identical so registry entry (easier) used)"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Eirion Slade"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"07/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1fdBEsYbFGZsS7YkX6-3g_7uSklWrp3YpHM13-Cf9kBs/edit"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"07/12/2015"},"gsx$secondassessorname":{"$t":"Aaron Dale"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"See comments sheet"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"19"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"18"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"8"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1UjJ9lDW5oDFILb6VoiUOzTaH0-Gi-QVnibpnhjydXxE/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"KM 8/12"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"08/12/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"ES 09/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a832w"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"70"},"content":{"type":"text","$t":"journalname: BMJ, trialtitle: Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial, publicationdate: 23/11/2015, linktoonlinetrialreport: https://www.bmj.com/content/351/bmj.h6127, linktoonlinereistryentryfortrial: https://www.trialregister.nl/trialreg/admin/rctview.asp?TC\u003d3296, linktopre-trialprotocolifavailable: https://www.biomedcentral.com/1471-244X/13/209, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Henry Drysdale, assigneddate: 27/11/2015, completiondate: 28/11/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1CyZx5y3n7_ReQlaGWenbCBIhPn5pnfLIg7J8UlbMc-Q/edit#gid\u003d0\u0026vpid\u003dA1, assessmentcheckedbysecondassessor-date: 16/12/2015, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, secondassessordiscrepanciesfreetext: See comments on sheet, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomescorrectlyreported: 0, totalnumberofprespecifiedsecondaryoutcomes: 7, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 0, totalnumberofnon-prespecifiedoutcomesreported: 22, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Not Sure, finaldecision-letterrequired: Yes, linktoletter: https://docs.google.com/document/d/1SAuPf-gz91PeqrYGxRw6i3J8YkYEU4iPcOJAw-ZLS8U/edit, lettercheckedbybgorch-initialanddate: CH 18/1/16, lettersubmissiondeadline: BMJ, lettersentdate: 19/01/2016, letterstatus: Letter published, letterpublisheddate: 19/01/2016, resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate: HD 18/01"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a832w"}],"gsx$studyid":{"$t":"70"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"BMJ"},"gsx$trialtitle":{"$t":"Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial"},"gsx$publicationdate":{"$t":"23/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.bmj.com/content/351/bmj.h6127"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://www.trialregister.nl/trialreg/admin/rctview.asp?TC\u003d3296"},"gsx$linktopre-trialprotocolifavailable":{"$t":"https://www.biomedcentral.com/1471-244X/13/209"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Henry Drysdale"},"gsx$assigneddate":{"$t":"27/11/2015"},"gsx$completiondate":{"$t":"28/11/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1CyZx5y3n7_ReQlaGWenbCBIhPn5pnfLIg7J8UlbMc-Q/edit#gid\u003d0\u0026vpid\u003dA1"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":"16/12/2015"},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":"See comments on sheet"},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":""},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"7"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"0"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"22"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Not Sure"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://docs.google.com/document/d/1SAuPf-gz91PeqrYGxRw6i3J8YkYEU4iPcOJAw-ZLS8U/edit"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"CH 18/1/16"},"gsx$lettersubmissiondeadline":{"$t":"BMJ"},"gsx$lettersentdate":{"$t":"19/01/2016"},"gsx$letterstatus":{"$t":"Letter published"},"gsx$letterpublisheddate":{"$t":"19/01/2016"},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":"HD 18/01"},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}},{"id":{"$t":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a9hnd"},"updated":{"$t":"2019-11-06T02:01:25.312Z"},"category":[{"scheme":"https://schemas.google.com/spreadsheets/2006","term":"https://schemas.google.com/spreadsheets/2006#list"}],"title":{"type":"text","$t":"71"},"content":{"type":"text","$t":"journalname: Lancet, trialtitle: Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial , publicationdate: 30/11/2015, linktoonlinetrialreport: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01021-1/abstract, linktoonlinereistryentryfortrial: https://clinicaltrials.gov/show/NCT00323960, linktopre-trialprotocolifavailable: Not available, pre-specifiedoutcomesobtainedfromprotocolorregistryentry: Registry Entry, assessorname: Aaron Dale, assigneddate: 30/11/2015, completiondate: 13/12/2015, linktoassessment: https://docs.google.com/spreadsheets/d/1AhYWodGyi-qz4cYYv8VM4ckTBl1maFAQT1NWar8DDxY/edit#gid\u003d0, secondassessorname: Ioan Milosevic, secondassessordiscrepancies: Yes, totalnumberofprespecifiedprimaryoutcomes: 1, numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable: 0, numberofprespecifiedprimaryoutcomescorrectlyreported: 1, totalnumberofprespecifiedsecondaryoutcomes: 3, numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable: 0, numberofprespecifiedsecondaryoutcomescorrectlyreported: 3, totalnumberofnon-prespecifiedoutcomesreported: 16, numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper: 0, firstassessoropinion-letterrequired: Yes, secondassessoropinion-letterrequired: Yes, finaldecision-letterrequired: Yes, linktoletter: https://drive.google.com/open?id\u003d1ghWgXS3hodd-AxiwQ6kno2R-40NCxCZZ2VKa55X6Uxk, lettercheckedbybgorch-initialanddate: BG 14th dec, lettersubmissiondeadline: #REF!, lettersentdate: 14/12/2015, letterstatus: Letter unpublished after 4 weeks"},"link":[{"rel":"self","type":"application/atom+xml","href":"https://spreadsheets.google.com/feeds/list/1EgNcKJ_p4v7P0JNq5GSElKGvDX88z8QZN52n8C-yQAc/od6/public/values/a9hnd"}],"gsx$studyid":{"$t":"71"},"gsx$weekbeginning":{"$t":""},"gsx$journalname":{"$t":"Lancet"},"gsx$trialtitle":{"$t":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial "},"gsx$publicationdate":{"$t":"30/11/2015"},"gsx$linktoonlinetrialreport":{"$t":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01021-1/abstract"},"gsx$linktoonlinereistryentryfortrial":{"$t":"https://clinicaltrials.gov/show/NCT00323960"},"gsx$linktopre-trialprotocolifavailable":{"$t":"Not available"},"gsx$pre-specifiedoutcomesobtainedfromprotocolorregistryentry":{"$t":"Registry Entry"},"gsx$assessorname":{"$t":"Aaron Dale"},"gsx$assigneddate":{"$t":"30/11/2015"},"gsx$completiondate":{"$t":"13/12/2015"},"gsx$linktoassessment":{"$t":"https://docs.google.com/spreadsheets/d/1AhYWodGyi-qz4cYYv8VM4ckTBl1maFAQT1NWar8DDxY/edit#gid\u003d0"},"gsx$assessmentcheckedbysecondassessor-date":{"$t":""},"gsx$secondassessorname":{"$t":"Ioan Milosevic"},"gsx$secondassessordiscrepancies":{"$t":"Yes"},"gsx$secondassessordiscrepanciesfreetext":{"$t":""},"gsx$totalnumberofprespecifiedprimaryoutcomes":{"$t":"1"},"gsx$numberofprespecifiedprimaryoutcomesreportedsomewhereinthepublicationotherthatmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedprimaryoutcomescorrectlyreported":{"$t":"1"},"gsx$totalnumberofprespecifiedsecondaryoutcomes":{"$t":"3"},"gsx$numberofprespecifiedsecondaryoutcomesreportedsomewhereinthepublicationotherthanmainresultstable":{"$t":"0"},"gsx$numberofprespecifiedsecondaryoutcomescorrectlyreported":{"$t":"3"},"gsx$totalnumberofnon-prespecifiedoutcomesreported":{"$t":"16"},"gsx$numberofnon-prespecifiedoutcomescorrectlyreportedienoveloutcomesbutdescribedassuchinthepaper":{"$t":"0"},"gsx$firstassessoropinion-letterrequired":{"$t":"Yes"},"gsx$secondassessoropinion-letterrequired":{"$t":"Yes"},"gsx$finaldecision-letterrequired":{"$t":"Yes"},"gsx$linktoletter":{"$t":"https://drive.google.com/open?id\u003d1ghWgXS3hodd-AxiwQ6kno2R-40NCxCZZ2VKa55X6Uxk"},"gsx$lettercheckedbybgorch-initialanddate":{"$t":"BG 14th dec"},"gsx$lettersubmissiondeadline":{"$t":"#REF!"},"gsx$lettersentdate":{"$t":"14/12/2015"},"gsx$letterstatus":{"$t":"Letter unpublished after 4 weeks"},"gsx$letterpublisheddate":{"$t":""},"gsx$resultsletterassessmentcheckedforwebsite-1stassessorinitialanddate":{"$t":""},"gsx$publicationdelay":{"$t":""},"gsx$complicationsandmattersarisinginfreetext":{"$t":""}}]}});
